Loomis, Sayles & Company’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.7M | Sell |
|
|||||
|
2025
Q1 | $31M | Sell |
|
|||||
|
2024
Q4 | $35.9M | Sell |
|
|||||
|
2024
Q3 | $44.4M | Sell |
|
|||||
|
2024
Q2 | $54.3M | Sell |
|
|||||
|
2024
Q1 | $69.9M | Sell |
|
|||||
|
2023
Q4 | $66.8M | Sell |
|
|||||
|
2023
Q3 | $49.8M | Sell |
|
|||||
|
2023
Q2 | $64.4M | Sell |
|
|||||
|
2023
Q1 | $52.3M | Sell |
|
|||||
|
2022
Q4 | $48.3M | Sell |
|
|||||
|
2022
Q3 | $81.4M | Sell |
|
|||||
|
2022
Q2 | $84.8M | Buy |
|
|||||
|
2022
Q1 | $81M | Sell |
|
|||||
|
2021
Q4 | $99.7M | Buy |
|
|||||
|
2021
Q3 | $104M | Buy |
|
|||||
|
2021
Q2 | $147M | Buy |
|